EP300 and lung carcinoma: In addition, we also assessed the expression levels of these A-ERGs in T cells across all samples and found that, compared to the control group, the expression of most A-ERGs was consistently higher in the lung cancer group, except for KDM3B, EP300, MECP2, and KDM6A (Figure 3G).